These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9160696)

  • 1. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants.
    Reusser P; Attenhofer R; Hebart H; Helg C; Chapuis B; Einsele H
    Blood; 1997 May; 89(10):3873-9. PubMed ID: 9160696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.
    Reusser P; Riddell SR; Meyers JD; Greenberg PD
    Blood; 1991 Sep; 78(5):1373-80. PubMed ID: 1652311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytomegalovirus-specific CD4+ cytotoxic T lymphocytes from seropositive or negative healthy subjects or stem cell transplant recipients.
    Tazume K; Hagihara M; Gansuvd B; Higuchi A; Ueda Y; Hirabayashi K; Hojo M; Tanabe A; Okamoto A; Kato S; Hotta T
    Exp Hematol; 2004 Jan; 32(1):95-103. PubMed ID: 14725906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load.
    Reusser P; Cathomas G; Attenhofer R; Tamm M; Thiel G
    J Infect Dis; 1999 Aug; 180(2):247-53. PubMed ID: 10395836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation.
    Foster AE; Gottlieb DJ; Sartor M; Hertzberg MS; Bradstock KF
    Biol Blood Marrow Transplant; 2002; 8(9):501-11. PubMed ID: 12374455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
    Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
    Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.
    Cwynarski K; Ainsworth J; Cobbold M; Wagner S; Mahendra P; Apperley J; Goldman J; Craddock C; Moss PA
    Blood; 2001 Mar; 97(5):1232-40. PubMed ID: 11222365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis.
    Li CR; Greenberg PD; Gilbert MJ; Goodrich JM; Riddell SR
    Blood; 1994 Apr; 83(7):1971-9. PubMed ID: 8142663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
    N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.
    Zhou W; Longmate J; Lacey SF; Palmer JM; Gallez-Hawkins G; Thao L; Spielberger R; Nakamura R; Forman SJ; Zaia JA; Diamond DJ
    Blood; 2009 Jun; 113(25):6465-76. PubMed ID: 19369230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
    Lindsley MD; Torpey DJ; Rinaldo CR
    J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients.
    Singhal S; Shaw JC; Ainsworth J; Hathaway M; Gillespie GM; Paris H; Ward K; Pillay D; Moss PA; Mutimer DJ
    Transplantation; 2000 Jun; 69(11):2251-9. PubMed ID: 10868622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of in vivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood/bone marrow mixed grafts.
    Luo XH; Huang XJ; Li D; Liu KY; Xu LP; Liu DH
    Transpl Infect Dis; 2013 Feb; 15(1):22-33. PubMed ID: 22372613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions.
    Peggs K; Verfuerth S; Mackinnon S
    Blood; 2001 Feb; 97(4):994-1000. PubMed ID: 11159528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.